Evaluation and management of pediatric patients with anaphylactoid reactions to deferoxamine mesylate.
Somech
Raz
R
Seaban-Adel
Kimberley
K
Atkinson
Adelle
A
Kirby-Allen
Melanie
M
D000293:Adolescent; D000707:Anaphylaxis / Q000139:chemically induced* / Q000517:prevention & control / Q000628:therapy*; D002648:Child; D003676:Deferoxamine / Q000009:adverse effects* / Q000627:therapeutic use; D003888:Desensitization, Immunologic; D006801:Humans; D017262:Siderophores / Q000009:adverse effects* / Q000627:therapeutic use; D012882:Skin Tests
D017262:Siderophores; D003676:Deferoxamine